Important: This article summarises UK guidance and cannot determine whether you are protected from pregnancy. Do not start, stop or change a GLP-1 medicine or contraceptive based only on this page. Follow the current product leaflet and advice from your prescriber or pharmacist.

First, Identify the Medicine

Brand names can obscure an important difference:

BrandActive ingredientCurrent UK oral-contraception point
MounjaroTirzepatideAdd a barrier method for four weeks after starting and four weeks after each dose increase, or discuss a non-oral method
OzempicSemaglutideNo Mounjaro-style precaution solely because of a direct interaction; sickness can still affect pill absorption
WegovySemaglutideNo Mounjaro-style precaution solely because of a direct interaction; sickness can still affect pill absorption
RybelsusSemaglutideFollow the prescriber and leaflet; sickness can affect pill absorption
Saxenda and other liraglutide brandsLiraglutideFollow the prescriber and leaflet; sickness can affect pill absorption

This table summarises UK advice checked on 20 June 2026. Product information and regulatory guidance can change, so confirm it when treatment is started, changed or increased.

Why Mounjaro Has Additional Advice

Tirzepatide delays stomach emptying, particularly after treatment begins and after the dose is increased. This can alter how an oral contraceptive is absorbed. The MHRA therefore recommends an additional barrier method for four weeks after starting and for four weeks after every dose increase, or use of a non-oral contraceptive method.

Do not assume the precaution is needed only after the first injection. Mounjaro is commonly increased in steps, and each increase starts a new four-week precaution period under current UK advice.

Does This Affect Both Combined and Progestogen-Only Pills?

The MHRA wording applies to oral contraceptives. That includes combined and progestogen-only pills because both depend on tablets being absorbed. Do not assume a mini-pill avoids the Mounjaro advice simply because it contains no oestrogen.

Non-oral methods, such as the implant, coil, injection, patch or vaginal ring, do not rely on gastrointestinal absorption. They are not all suitable for every person, and the patch and ring still contain oestrogen, so a clinician should consider your medical eligibility before switching.

What About Ozempic, Wegovy and Other GLP-1 Medicines?

The specific four-week oral-contraception precaution is attached to tirzepatide in current UK advice. Specialist UK guidance has not recommended the same routine additional barrier period for semaglutide, liraglutide, dulaglutide or exenatide solely because of a direct drug interaction. That does not make the question irrelevant: GLP-1 medicines commonly cause nausea, vomiting or diarrhoea, especially after starting or increasing a dose, and those effects can make any oral pill less reliable if the tablet is not absorbed.

Vomiting and diarrhoea are a separate route to reduced protection. If you vomit soon after taking a contraceptive pill, or have severe or prolonged diarrhoea, follow the sickness instructions for your exact pill. See Vomiting or Diarrhoea on the Pill: Are You Still Protected? for the scenario guide; this article does not duplicate those rules.

Free on Android

Keep a clear record through dose changes

Estroclic records your pill-taking times, brand and missed or late doses. The Safety Hub links to your brand's official patient information leaflet, so you have a clear pill record when discussing dose increases or precautions with a pharmacist or prescriber.

Get the app free

What If I Recently Started Mounjaro Without Additional Contraception?

Do not try to calculate pregnancy risk from this article. Contact a pharmacist, sexual-health service, GP or NHS 111 promptly, particularly if you had sex without a barrier method during the four weeks after starting or increasing the dose. Emergency contraception is time-sensitive and its choice can interact with ongoing hormonal contraception. Do not stop either prescribed medicine abruptly unless a healthcare professional tells you to.

Should I Switch Away From the Pill?

Not necessarily. Some people prefer to use condoms during each four-week precaution period; others prefer a method that is not swallowed if several dose increases are planned. The right choice depends on medical eligibility, bleeding preferences, pregnancy plans and how comfortable you are managing repeated precaution windows. Useful questions for your prescriber include how many dose increases are planned, when each four-week period begins and ends, which barrier method to use, and what to do if you vomit or have diarrhoea.

GLP-1 Medicines, Pregnancy and Breastfeeding

MHRA guidance says GLP-1 medicines should not be used during pregnancy or while breastfeeding. Anyone who thinks they may be pregnant while taking one should contact a healthcare professional promptly. Current MHRA guidance also gives medicine-specific intervals before trying to become pregnant: at least two months after stopping semaglutide and at least one month after stopping tirzepatide; liraglutide should be stopped before trying. These are not instructions to change treatment independently; pregnancy planning should be discussed with the GLP-1 prescriber.

Important: seek prompt professional advice after unprotected sex when an interaction or absorption problem may have reduced protection. In the UK, contact a pharmacist, sexual-health service, GP or NHS 111.

The Bottom Line

  • The key distinction is tirzepatide (Mounjaro) versus other GLP-1 medicines, plus whether sickness affects absorption.
  • Mounjaro users on an oral contraceptive should add a barrier method for four weeks after starting and four weeks after every dose increase, or discuss a non-oral method.
  • Ozempic, Wegovy and other GLP-1 medicines do not carry the same routine precaution, but vomiting and diarrhoea remain a separate risk to absorption.
  • The advice applies to both combined and progestogen-only oral pills.
  • GLP-1 medicines should not be used during pregnancy or while breastfeeding; pregnancy planning needs the GLP-1 prescriber's input.

Frequently Asked Questions

How long should I use condoms after starting Mounjaro?

Current UK advice says four weeks after starting tirzepatide (Mounjaro) and four weeks after every dose increase when relying on an oral contraceptive. Confirm the dates with the prescriber or pharmacist.

Does Ozempic make the contraceptive pill stop working?

Current UK guidance does not apply Mounjaro's routine four-week precaution to semaglutide solely because of a direct interaction. Vomiting or diarrhoea can still reduce absorption of an oral pill.

Does Mounjaro affect the mini-pill as well as the combined pill?

The MHRA advice refers to oral contraceptives, so do not assume the progestogen-only pill is exempt. Ask about additional contraception or a non-oral method.

What if I had sex without condoms after a Mounjaro dose increase?

Seek prompt advice from a pharmacist, sexual-health service, GP or NHS 111. Emergency contraception is time-sensitive, and the service needs the dates, Mounjaro dose and exact contraceptive pill.

This article is for general informational purposes only and does not constitute medical, pharmaceutical or clinical advice. The information reflects published NHS, CoSRH/FSRH and MHRA guidance at the time of writing and may not reflect the most current guidance in your country or for your individual circumstances. Always read the patient information leaflet supplied with your medicine and consult your doctor, pharmacist or other qualified healthcare professional before making any decisions about your contraception or health. Estroclic is a personal tracking app, not a medical device or clinical service.